Exploration of the comprehensive management practice pathway for long-term prescription medications in psychiatry
- VernacularTitle:精神科长期处方药品综合管理实践路径的探索
- Author:
Mengxi NIU
1
,
2
;
Pengfei LI
1
,
2
;
Xue WANG
1
,
2
;
Shanshan LIU
1
,
2
;
Yanxiang CAO
1
,
2
;
Hongyan ZHUANG
1
,
2
;
Hu WANG
1
,
2
;
Li BAI
1
,
2
;
Huawei LI
1
,
2
;
Fei PAN
1
,
2
;
Sha SHA
1
,
2
;
Qing’e ZHANG
1
Author Information
1. Beijing Key Laboratory of Critical Bridging Technologies for Chronic Disease Drug Development/Pharmacy Department,Beijing Anding Hospital,Capital Medical University,Beijing 100088,China
2. Advanced Innovation Center for Human Brain Protection,Capital Medical University,Beijing 100069,China
- Publication Type:Journal Article
- Keywords:
long-term prescriptions;
mental disorders;
chronic disease;
psychotropic drugs;
adherence;
pharmaceutical services
- From:
China Pharmacy
2025;36(19):2366-2371
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To explore comprehensive management and potential issues associated with long-term prescriptions medications of psychiatry, in order to provide a reference for the comprehensive management of long-term prescriptions of psychiatry in psychiatric hospitals and other medical institutions’ pharmacies. METHODS Starting from the applicable principles for long-term prescriptions of psychiatry, this study introduced the standardized assessment and precautions before issuing long-term prescriptions, the formulation and adjustment of the drug list, as well as the rational management of the long-term prescriptions. It also analyzed potential issues that may arise in the comprehensive management of long-term prescription medications and proposed corresponding countermeasures and suggestions. RESULTS & CONCLUSIONS Prior to initiating long-term prescriptions, a standardized assessment should be conducted on patients from the aspects of their psychiatric condition and long-term potential risk factors, pharmacological treatment plans and other non-pharmacological therapies, physical illnesses. Additionally, healthcare providers should fulfill their obligation to inform patients or their family members. The comprehensive management of long-term prescription medications should be jointly established and improved by multiple departments, and the formulation of drug catalogs should avoid including drugs with potential social harm or medication risks while complying with policy requirements. Furthermore, measures such as adding special identifiers to long-term prescriptions, providing patients with reminders about (No.YGLX202537) prescription expiration, or offering online consultations can also effectively enhance the rationality of medication use under long-term prescriptions. Currently, the implementation of long-term prescriptions in psychiatry remains challenged by inconsistencies in prescription duration, incomplete coverage of diagnostic categories, poor patient adherence, and the risk of deviation in clinical assessments. In this regard, measures such as collaborating with multiple departments to strengthen long-term prescription information management, providing matching pharmaceutical services, ensuring the quality and rationality of long-term prescription implementation, and using modern methods to screen high-risk patients can be taken to improve patient medication compliance and safety.